SMI# 9
CAS: 1002789-86-7
Ref. 3D-CQB78986
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Informação sobre produto
SMI# 9 is a benzoate that inhibits the proliferation of cancer cells by binding to PD-L1, which is a protein expressed in many types of cancer cells. SMI# 9 also has anticancer activity against breast and prostate cancers, as well as melanoma. The compound was shown to have predictive biomarker properties in an assay with human breast tumor tissue samples, which may be due to the inhibition of the expression of mcf-7. SMI# 9 binds to the triazine site on pd-l1, which prevents it from binding to its receptor and blocks the activation of immune cells. This drug has been tested in clinical trials for safety and efficacy in patients with advanced solid tumors and is currently undergoing Phase III clinical trials.
Propriedades químicas
Consulta técnica sobre: 3D-CQB78986 SMI# 9
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
